GENE to Launch World’s First Comprehensive Risk Test for Breast & Ovarian Cancer

Posted: February 6, 2023 at 12:50 am

MELBOURNE, Australia, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”) a global leader in genomics-based tests in health, wellness and serious disease, is pleased to announce the Company will launch a ‘World First’ Comprehensive Risk Assessment Test which evaluates a women’s risk of developing Breast and/or Ovarian Cancer either from a hereditary genetic mutation or from the far more common familial or sporadic cancer. Combined with other clinical risk factors the test provides a comprehensive risk assessment in a simple saliva test.

Read this article:
GENE to Launch World’s First Comprehensive Risk Test for Breast & Ovarian Cancer

Related Posts